Market Value1,764,757,717
Total Holdings75
File Date2024-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
OCUL / Ocular Therapeutix, Inc.
THC / Tenet Healthcare Corporation
EYPT / EyePoint, Inc.
APLS / Apellis Pharmaceuticals, Inc.
SANA / Sana Biotechnology, Inc.
QQQ / Invesco QQQ Trust, Series 1 Call
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
DAWN / Day One Biopharmaceuticals, Inc.
WAT / Waters Corporation
OSCR / Oscar Health, Inc.
CGEM / Cullinan Therapeutics, Inc.
CLDX / Celldex Therapeutics, Inc.
WAY / Waystar Holding Corp.
ELV / Elevance Health, Inc.
TNYA / Tenaya Therapeutics, Inc.
CAPR / Capricor Therapeutics, Inc.
ALKS / Alkermes plc
XBI / SPDR Series Trust - State Street SPDR S&P Biotech ETF Call
CNC / Centene Corporation
ACHC / Acadia Healthcare Company, Inc.
EW / Edwards Lifesciences Corporation
MCK / McKesson Corporation
PRAX / Praxis Precision Medicines, Inc.
BSX / Boston Scientific Corporation
UHS / Universal Health Services, Inc.
SYK / Stryker Corporation
MDGL / Madrigal Pharmaceuticals, Inc.
SGMT / Sagimet Biosciences Inc.
PEN / Penumbra, Inc.
TGTX / TG Therapeutics, Inc.
QURE / uniQure N.V.
XENE / Xenon Pharmaceuticals Inc.
VRTX / Vertex Pharmaceuticals Incorporated
SNDX / Syndax Pharmaceuticals, Inc.
AXSM / Axsome Therapeutics, Inc.
ICLR / ICON Public Limited Company
INSM / Insmed Incorporated
ACLX / Arcellx, Inc.
KROS / Keros Therapeutics, Inc.
IMVT / Immunovant, Inc.
LUNG / Pulmonx Corporation
GBIO / Generation Bio Co.
CYTK / Cytokinetics, Incorporated
UNH / UnitedHealth Group Incorporated
TMO / Thermo Fisher Scientific Inc.
EPIX / ESSA Pharma Inc.
CELC / Celcuity Inc.
AMGN / Amgen Inc.
VERV / Verve Therapeutics, Inc.
MRK / Merck & Co., Inc.
ITCI / Intra-Cellular Therapies, Inc.
BOLD / Boundless Bio, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
JNJ / Johnson & Johnson
INSP / Inspire Medical Systems, Inc.
MOH / Molina Healthcare, Inc.
HCA / HCA Healthcare, Inc.
VEEV / Veeva Systems Inc.
BDX / Becton, Dickinson and Company
DXCM / DexCom, Inc.
MGX / Metagenomi Therapeutics, Inc.
PMVP / PMV Pharmaceuticals, Inc.
IQV / IQVIA Holdings Inc.
US803607AD25 / CONV. NOTE
DHR / Danaher Corporation
ARKG / ARK ETF Trust - ARK Genomic Revolution ETF
ASND / Ascendis Pharma A/S
ISRG / Intuitive Surgical, Inc.
ASND / Ascendis Pharma A/S
VKTX / Viking Therapeutics, Inc.
SRPT / Sarepta Therapeutics, Inc.
TSBX / Turnstone Biologics Corp.
UNH / UnitedHealth Group Incorporated Call
IOBT / IO Biotech, Inc.
ABBV / AbbVie Inc.
INXB.V / Inhibrx Biosciences, Inc.
LLY / Eli Lilly and Company
HUM / Humana Inc.
XBI / SPDR Series Trust - State Street SPDR S&P Biotech ETF
CRBU / Caribou Biosciences, Inc.
IWM / iShares Trust - iShares Russell 2000 ETF Put
CON / Concentra Group Holdings Parent, Inc.
HOWL / Werewolf Therapeutics, Inc.
IOVA / Iovance Biotherapeutics, Inc.
OM / Outset Medical, Inc.
LBPH / Longboard Pharmaceuticals, Inc.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
ERAS / Erasca, Inc.